Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds
Natco Pharma logs highest-ever sales, net in FY25, wary of headwinds for U.S. business in FY26
Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29